Reaction equation
Cl[C:2]1[N:3]=[C:4]([C:19]2[O:20][CH:21]=[CH:22][CH:23]=2)[C:5]2[CH:10]=[CH:9][N:8]([CH2:11][C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=3[F:18])[C:6]=2[N:7]=1.[CH2:24]([NH2:35])[C:25]1[CH:34]=[CH:33][C:30]([O:31][CH3:32])=[C:27]([O:28][CH3:29])[CH:26]=1>CN1CCCC1=O>[CH3:29][O:28][C:27]1[CH:26]=[C:25]([CH:34]=[CH:33][C:30]=1[O:31][CH3:32])[CH2:24][NH:35][C:2]1[N:3]=[C:4]([C:19]2[O:20][CH:21]=[CH:22][CH:23]=2)[C:5]2[CH:10]=[CH:9][N:8]([CH2:11][C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=3[F:18])[C:6]=2[N:7]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 100 °C
Procedure
A solution of 2-chloro-7-(2-fluorobenzyl)-4-(2-furyl)-7H-pyrrolo[2,3-d]pyrimidine (254 mg, 0.78 mmol) in N-methylpyrrolidone (2 mL) was treated with veratrylamine (0.25 mL, 1.66 mmol), heated to 100° C. for 16 h and purified by chromatography (Heptane:EtOAc, 4:1) to give the title compound (316 mg, 88%) as a cream solid.
Workup
- custompurified by chromatography (Heptane:EtOAc, 4:1)
Sources & evidence
- ORD record
- ord-1c36fde3337d4a65b799365dc4a52858
- Source dataset
- uspto-grants-2009_10
- Patent number
- US07598256B2
Linked notes
Loading…